WHO slams US-funded newborn vaccine trial as "unethical"
Summary
Ars Technica reports that the World Health Organization labeled a US-funded newborn hepatitis B birth-dose vaccine trial in Guinea-Bissau as unethical, citing withholding a proven lifesaving intervention and concerns about trial design. The piece details funding by the CDC, opposition from health experts, suspension status, and the broader policy implications surrounding vaccine governance and global health equity.